OptiNose, Inc. (OPTN)
9.60
-0.11 (-1.13%)
Inactive · Last trade price on May 20, 2025
OptiNose Employees
As of December 31, 2024, OptiNose had 128 total employees, including 127 full-time and 1 part-time employees. The number of employees decreased by 4 or -3.03% compared to the previous year.
Employees
128
Change (1Y)
-4
Growth (1Y)
-3.03%
Revenue / Employee
$639,500
Profits / Employee
-$233,516
Market Cap
97.22M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 128 | -4 | -3.03% |
| Dec 31, 2023 | 132 | -9 | -6.38% |
| Dec 31, 2022 | 141 | -51 | -26.56% |
| Dec 31, 2021 | 192 | -15 | -7.25% |
| Dec 31, 2020 | 207 | -17 | -7.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
OPTN News
- 3 months ago - OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc. - OPTN - Business Wire
- 5 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BECN and OPTN on Behalf of Shareholders - GlobeNewsWire
- 5 months ago - Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call - GlobeNewsWire
- 5 months ago - Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS) - GlobeNewsWire
- 7 months ago - Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million - GlobeNewsWire
- 8 months ago - Optinose Announces 1-for-15 Reverse Stock Split - GlobeNewsWire
- 9 months ago - Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 9 months ago - OptiNose, Inc. (OPTN) Q3 2024 Earnings Call Transcript - Seeking Alpha